Navigation Links
Analysis Shows BYDUREON™ Was Not Associated with Clinically Relevant QT Prolongation in Patients with Type 2 Diabetes: Results Presented at ADA 2011
Date:6/24/2011

SAN DIEGO, June 24, 2011 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced results from an analysis of the DURATION-1 study that showed the investigational type 2 diabetes medication BYDUREON™ (exenatide extended-release for injectable suspension) was not associated with clinically relevant QT prolongation in patients with type 2 diabetes. These findings will be presented in a poster session at the 71st Scientific Sessions of the American Diabetes Association in San Diego on Saturday, June 25 from 11:30 a.m. to 1:30 p.m. PDT.

The QT interval represents the amount of time the heart's electrical system takes to repolarize, or recharge, after each beat.(i) Drugs that substantially prolong the QT interval have been associated with cardiac arrhythmias.

This analysis used data from the DURATION-1 study to evaluate changes in the QT interval associated with BYDUREON, correcting for heart rate with Fridericia's formula (QTcF). The change in QTcF from baseline was small and clinically insignificant at 14 weeks (1.7 milliseconds) and 30 weeks (3.0 milliseconds). There was no correlation between change in QTcF and exenatide blood plasma concentrations or renal status.

"These results suggest BYDUREON does not produce clinically relevant QT prolongation," said Christian Weyer, M.D., senior vice president, research and development, Amylin Pharmaceuticals. "To further characterize the QT-related safety of BYDUREON, we are currently conducting a thorough QT study according to guidelines set by the FDA. We believe that BYDUREON could be an important treatment option for patients with type 2 diabetes, and we continue to
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Eli Lilly and Company; Alkermes, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S.
2. Analysis Finds BYETTA® Associated with Lower Likelihood of Heart Failure Compared with Other Diabetes Therapies: Results Presented at ADA 2011
3. PRA Early Phase Leaders to Speak at Bioanalysis Forum
4. Dr. Assad Al-Ammar Joins Irvine Pharmaceutical Services as the New Minerals Analysis Manager in Response to the Growing Needs for USP Elemental Impurities Testing
5. Reportlinker Adds Distributor Analysis of the Pharmaceutical Industry in Key SADC Countries
6. Post Hoc Analysis from RECOVER Study Examined Effects of Neupro® (Rotigotine Transdermal System) on Surrogate Markers of Mood and Anhedonia in Parkinsons Disease
7. ForteBio Introduces New Biosensor for Kinetic Analysis and Screening of Mouse IgG Antibodies
8. Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
9. Reportlinker Adds Hip Replacement Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
10. Reportlinker Adds Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
11. Reportlinker Adds Hearing Aid Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 25, 2014 /PRNewswire-iReach/ -- Dr. Michael Gabriel of ... reacts to a recent study, which shows how grief in ... http://photos.prnewswire.com/prnh/20140723/129709 According to US ... are more likely than others to grow up overweight or ... There were two specific types of stress that caused ...
(Date:7/24/2014)...  PTC Therapeutics, Inc. (NASDAQ: PTCT ) ... conference call to report its second quarter 2014 financial ... and outlook on Thursday, August 7, 2014 at 8:30 ... The call can be accessed by dialing ... prior to the start of the call and providing ...
(Date:7/24/2014)... , Germany , and ... -- , Exclusive global license ... for SF3B1 mutations, including next-generation sequencing (NGS) gene panels, ... to be targeted by new test, indicate favorable prognosis ... syndromes  QIAGEN sees potential for developing companion ...
Breaking Medicine Technology:Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 4QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 5
... Dec. 5, 2010 Pfizer Inc. (NYSE: ... has elected Ian C. Read, 57, currently head of ... Officer and Director. Mr. Read succeeds Jeffrey B. Kindler, ... (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) The Board,s Lead Independent Director, ...
... The Infectious Disease Research Institute (IDRI) has ... Advance Research and Development Authority (BARDA). IDRI,s work will ... to $8.5 million over three years when further development ... agency. "BARDA is supporting an important ...
Cached Medicine Technology:Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer 2Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer 3Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer 4IDRI Awarded Contract from BARDA to Develop Next Generation Adjuvants for Pandemic Influenza 2
(Date:7/25/2014)... are more easily distracted during thinking and memory tasks ... any type of memory test administered reveals a decline ... co-author Randi Martin, professor of psychology at Rice University, ... said, this study shows that "environmental interference" has a ... younger adults. The study included 60 seniors, aged ...
(Date:7/25/2014)... USA (PRWEB) July 25, 2014 As reported ... Use, OD Deaths Increase (7/20), Michigan has seen a nearly ... four years. While the count was 271 between 1999 and ... range. DEA Agents believe that, like other states, drug users ... the drug via prescription pills. He compared the price of ...
(Date:7/25/2014)... Florida Hospital and MOSI officially announced a transformational partnership ... come and make a difference in the Tampa Bay community. ... to provide the support needed to keep the science center ... the IMAX Dome Theatre from film to a state-of-the-art digital ... Theatre in the state of Florida, and it is one ...
(Date:7/25/2014)... 2014 Merrill Corporation ( http://www.merrillcorp.com ... for the financial, legal, healthcare and other corporate ... business, Merrill DataSite, has been recognized as the ... at the M&A Awards 2014 event. ... entrepreneurs, management teams, advisors and financiers as they ...
(Date:7/25/2014)... 2014 A new study conducted by the ... 39 percent of all children in the survey under the age ... looked at 2,505 children during the years of 2011 and 2013. ... age. The final result was that about two out of ... these children were from lower-income families and were of East Asian ...
Breaking Medicine News(10 mins):Health News:Distractions Seem More Troublesome With Age 2Health News:Rise in Heroin Use, Overdose Deaths in Michigan 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 3Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 4Health News:Merrill DataSite Recognized as “Technology Provider of the Year” by GrowthBusiness at the M&A Awards 2014 Event 2Health News:North York Dental Provides Services to Toronto Children in Light of Growing Demand 2Health News:North York Dental Provides Services to Toronto Children in Light of Growing Demand 3
... collaborators have shown how to predict if a child ... being treated for cancer or another catastrophic disease is ... will help clinicians improve guidelines for managing these infected ... pneumonia among infants, children and adults during winter, frequently ...
... Naviscan PET Systems, a privately,held company and the ... Paul J. Mirabella as Chairman of the Board, in,addition ... the,addition of Dr. Abhi Acharya to the Board of ... Chief Executive Officer,in July 2007 bringing 32 years of ...
... 4 The sponsors of two of,Pittsburgh,s finest long ... General,s Office of approval of their intention to,bring their ... 1, 2008, the Sisters of the Holy Spirit and ... a 186 bed not,for profit long term care facility ...
... has identified a previously unsuspected protein as a key ... cancer therapy. The study, published by Cell Press in ... understanding of the molecular response to breast cancer therapies ... estrogen receptor and are dependent on estrogen signaling. Drugs ...
... YORK, February 4, 2008 The Juvenile Diabetes ... of type 1 diabetes research, announced today that ... company based in Winston-Salem, N.C. that focuses on ... Through its Industry Discovery and Development Partnership Program, ...
... to later learning deficits , , MONDAY, Feb. 4 (HealthDay ... exposed to alcohol during pregnancy but who don,t have ... a new study suggests. , "Eyeblink conditioning (EBC) ... a conditioned stimulus, such as a tone, with an ...
Cached Medicine News:Health News:St. Jude finds risk factors for severe RSV infection in immunocompromised children 2Health News:St. Jude finds risk factors for severe RSV infection in immunocompromised children 3Health News:Naviscan Announces a New Chairman and Board Member 2Health News:Pennsylvania Attorney General Approves Vincentian Collaborative System-Marian Manor Integration 2Health News:Unsuspected protein determines resistance to breast cancer treatment 2Health News:JDRF partners with Plureon to explore generating insulin-producing cells from adult stem cells 2Health News:Eye Blinks May ID Fetal Alcohol Exposure 2
... an automatic petri dish streaking machine. ... up to 180 pre inoculated petri ... in substantial cost savings. The ISOPLATER® ... standardizes streaking procedures and increases safety ...
Data review and analysis is carried out with the Acquidata Uromac software already supplied with Acquidata Uromac Lab based urodynamics systems...
A compact mobile System Cart gives mobility within your department. The cart accomodates the Uromac Median data processor, desktop computer, printer and provides stowage space. Patient related transd...
... for any clinical setting, offering an ... UDS procedure. Customize Delphis™ to your ... a Pocket PC, a Touchpad PC ... wireless technology allows you to focus ...
Medicine Products: